WELCOME TO THE CENTER OF EXCELLENCE
ADC MidWest is the premiere specialty anal cancer prevention practice.
OUR VALUES
They are what set us apart.
They clarify our identity, serve as a rallying point for our employees, and tell our patients what to expect.
We value:
- CUSTOMER SERVICE (we exceed your expectations)
- QUALITY (we do it right or don’t do it at all)
- INTELLECTUAL HORSEPOWER (we only hire the smartest in class)
- PERSISTENCE (we keep asking questions)
- EFFICIENCY (we work smarter not harder)
OUR HISTORY
LEADING THE WAY IN ANAL PRECANCER SCREEENING AND TREATMENT
ADC MidWest has earned its status as the Center of Excellence, by providing first class care to their patients for over 15 years. Dr. Gary Bucher has been at the helm of the practice’s Anal Dysplasia focus as he has continued to ensure that the PLWH, MSM and other high-risk groups receive the care they need from proficient certified providers performing HRA and HRA guided anal precancer treatment. In January 2015, ADC MidWest became an ANCHOR Study site. The practice screened 1,532 participants and enrolled 580 participants of the 4,446 total participants enrolled in the study. Each site was required to have 3 proficiency certified providers in HRA and 2 proficiency certified providers in anal precancer treatment. Over the 7 years of the study, Dr. Bucher has successfully trained, and proficiency certified 7 providers. He has the distinction of training and certifying the most providers at ADC MidWest out of all 24 ANCHOR Study sites.
Dr. Bucher’s success with the ANCHOR Study has led to ADC MidWest being officially added as a member of the NCI-supported clinical trials group founded in 1995 to support innovative trials for AIDS-related cancers. The AMC is composed of 36 clinical trial sites worldwide and five Working Groups. ADC MidWest is a member of the Human Papillomavirus (HPV) Working Group. The current goals of the HPV Working Group are to evaluate the safety and efficacy of new methods of prevention and treatment of anal and cervical cancers and precancer in PLWH, determine which proteins and genes in the blood and tumor specimens (also known as biologic correlates) will help predict a patient’s prognosis and response to treatment and the knowledge gained from this will be used to develop and test new treatment strategies and to train clinicians in HRA to expand expertise and availability of this procedure within the AMC.
Providers from the Chicagoland and surrounding areas refer their patients who are at high risk for anal cancer to Dr. Bucher and his team for specialized care. Dr. Bucher and his ADC MidWest team evaluate patients from referral providers at Ascension Health, Advocate Aurora Health, Northwestern University Medicine, Rush University Medical Center, University of Illinois-Chicago, University of Chicago Medicine, Stroger Cook County Health System including CORE Center and many community health centers located throughout Chicago and the surrounding areas.
THE FUTURE OF ANAL PRECANCER SCREENING
High risk HPV types can cause anal precancer. At least 90% of all anal cancers are caused by the HPV virus. The proposed DHHS guidelines for the prevention and treatment of anal cancer highly recommend treatment for ALL ANAL PRECANCER.
For this reason, it is important for high-risk groups to have anal precancer screening.
AT ADC MIDWEST, WE ARE FOCUSED ON YOUR BUTT HEALTH AND PROVIDING YOU WITH THREE MAJOR COMMITMENTS.
THE PROVIDER-PATIENT RELATIONSHIP
We get to know you and your medical history so that we can customize a treatment just for you.
THE CARE YOU NEED
At ADC MidWest, every test and treatment we recommend is based on evidence. We avoid unnecessary care that might put your health at risk. We just do what’s right for you, every time.
RESPECT, DIGNITY &
A LISTENING EAR
We will always listen to you and ask how you are feeling about your care. We recognize the importance of incorporating your personal values and priorities into treatment decisions.